Sanara MedTech (SMTI) Receivables (2010 - 2026)

Sanara MedTech has reported Receivables for 17 years, with the latest figure at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 14.8% year-over-year to $13.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (up 14.8% YoY), and the FY2025 full-year result was $12.0 million, down 11.19% from the prior year.
• Receivables for Q1 2026 stood at $13.6 million, up from $12.0 million in the prior quarter.
• The five-year high for Receivables was $13.6 million in Q1 2026, with the low at $9081.0 in Q2 2025.
• Historically, Receivables has averaged $5.7 million across 5 years, with a median of $5.5 million in 2022.
• Annual changes were most pronounced in 2023 — Receivables sank 98.2% — and 2025, when it jumped 51467.26%.
• Sanara MedTech's Receivables stood at $6.9 million in 2022, then rose by 23.44% to $8.5 million in 2023, then soared by 58.49% to $13.5 million in 2024, then dropped by 11.19% to $12.0 million in 2025, then advanced by 13.5% to $13.6 million in 2026.
• The last three Receivables figures came in at $13.6 million (Q1 2026), $12.0 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.